Two additional BRAF V600E CDxs are approved for use in melanoma (Table 3) and another two for other indications, therascreen BRAF V600E RGQ PCR Kit for colorectal cancer, and OncomineTM Dx Target Test for NSCLC (not shown). The gene discussed is BRAF; the disease is non-small cell lung carcinoma.